Literature DB >> 8419085

Relationship of in vitro phagocytosis of serotype 14 Streptococcus pneumoniae to specific class and IgG subclass antibody levels in healthy adults.

J E Lortan1, A S Kaniuk, M A Monteil.   

Abstract

The role of specific IgG2 antibody in the protection against serious infection with Streptococcus pneumoniae is unclear. We therefore decided to investigate the relationship between serum antibody levels and opsonization and phagocytosis of this microorganism. We have measured serum IgM, IgA and IgG subclass antibody specific for pneumococcal capsular polysaccharide and in vitro phagocytosis of serotype 14 pneumococcus by polymorphs, in healthy adults before and after immunization with Pneumovax II. IgM and IgG2 were the predominant anti-pneumococcal antibodies seen, IgA and IgG1 being present at low titre. No significant relationship of phagocytosis with specific IgM and IgA antibodies was found. However, both specific IgG1 and IgG2 antibodies in post-immunization sera correlated significantly with phagocytosis of the pneumococcus in the presence of complement (r = 0.57, P = 0.029 and r = 0.59, P = 0.022 respectively). After heat-inactivation, the remaining opsonic activity of sera correlated only with levels of specific IgG2 antibody (r = 0.61, P = 0.0006). Whereas phagocytosis supported by specific IgG1 and IgG2 antibody to serotype 14 pneumococcus after immunization is mediated by complement activation, IgG2-specific antibody in high titre may also be able to function by complement-independent interaction with Fc gamma receptors on polymorphs.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8419085      PMCID: PMC1554633          DOI: 10.1111/j.1365-2249.1993.tb03353.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  15 in total

1.  IgG subclass response and opsonization of Streptococcus pneumoniae after vaccination of healthy adults.

Authors:  E Bardardottir; S Jonsson; I Jonsdottir; A Sigfusson; H Valdimarsson
Journal:  J Infect Dis       Date:  1990-08       Impact factor: 5.226

2.  Pneumococcal polysaccharide vaccine in young adults and older bronchitics: determination of IgG responses by ELISA and the effect of adsorption of serum with non-type-specific cell wall polysaccharide.

Authors:  D M Musher; M J Luchi; D A Watson; R Hamilton; R E Baughn
Journal:  J Infect Dis       Date:  1990-04       Impact factor: 5.226

3.  Opsonic requirements for phagocytosis of Streptococcus pneumoniae types VI, XVIII, XXIII, and XXV.

Authors:  G S Giebink; J Verhoef; P K Peterson; P G Quie
Journal:  Infect Immun       Date:  1977-11       Impact factor: 3.441

4.  Immunoglobulin G class and subclass antibodies to pneumococcal capsular polysaccharides.

Authors:  D S Chudwin; S G Artrip; G Schiffman
Journal:  Clin Immunol Immunopathol       Date:  1987-07

5.  Heat labile opsonins to Pneumococcus. 3. The participation of immunoglobulin and of the alternate pathway of C3 activation.

Authors:  J A Winkelstein; H S Shin; W B Wood
Journal:  J Immunol       Date:  1972-06       Impact factor: 5.422

6.  Correlation of serum opsonins with in vitro phagocytosis of Streptococcus pneumoniae.

Authors:  D S Chudwin; S G Artrip; A Korenblit; G Schiffman; S Rao
Journal:  Infect Immun       Date:  1985-10       Impact factor: 3.441

7.  Pneumococcal vaccine in normal children. Primary and secondary vaccination.

Authors:  E M Lawrence; K M Edwards; G Schiffman; J M Thompson; W K Vaughn; P F Wright
Journal:  Am J Dis Child       Date:  1983-09

8.  Direct evidence that decreased serum opsonization of Streptococcus pneumoniae via the alternative complement pathway in sickle cell disease is related to antibody deficiency.

Authors:  A B Bjornson; J S Lobel
Journal:  J Clin Invest       Date:  1987-02       Impact factor: 14.808

9.  Characterization of the IgA receptor from human polymorphonuclear leucocytes.

Authors:  M Albrechtsen; G R Yeaman; M A Kerr
Journal:  Immunology       Date:  1988-06       Impact factor: 7.397

10.  IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors:  D J Barrett; E M Ayoub
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

View more
  19 in total

1.  Standardization of an opsonophagocytic assay for the measurement of functional antibody activity against Streptococcus pneumoniae using differentiated HL-60 cells.

Authors:  S Romero-Steiner; D Libutti; L B Pais; J Dykes; P Anderson; J C Whitin; H L Keyserling; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1997-07

Review 2.  The pneumococcal problem.

Authors:  S K Obaro; M A Monteil; D C Henderson
Journal:  BMJ       Date:  1996-06-15

3.  Assignment of immunoglobulin G1 and G2 concentrations to pneumococcal capsular polysaccharides 3, 6B, 14, 19F, and 23F in pneumococcal reference serum 89-SF.

Authors:  A Soininen; I Seppälä; T Wuorimaa; H Käyhty
Journal:  Clin Diagn Lab Immunol       Date:  1998-07

4.  Influence of smoking and race on immunoglobulin G subclass concentrations in early-onset periodontitis patients.

Authors:  S M Quinn; J B Zhang; J C Gunsolley; J G Schenkein; H A Schenkein; J G Tew
Journal:  Infect Immun       Date:  1996-07       Impact factor: 3.441

5.  Isotypes and opsonophagocytosis of pneumococcus type 6B antibodies elicited in infants and adults by an experimental pneumococcus type 6B-tetanus toxoid vaccine.

Authors:  G Vidarsson; S T Sigurdardottir; T Gudnason; S Kjartansson; K G Kristinsson; G Ingolfsdottir; S Jonsson; H Valdimarsson; G Schiffman; R Schneerson; I Jonsdottir
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

6.  A flow cytometric opsonophagocytic assay for measurement of functional antibodies elicited after vaccination with the 23-valent pneumococcal polysaccharide vaccine.

Authors:  J E Martinez; S Romero-Steiner; T Pilishvili; S Barnard; J Schinsky; D Goldblatt; G M Carlone
Journal:  Clin Diagn Lab Immunol       Date:  1999-07

7.  Priming of immunological memory by pneumococcal conjugate vaccine in children unresponsive to 23-valent polysaccharide pneumococcal vaccine.

Authors:  Markus A Rose; Ralf Schubert; Nicola Strnad; Stefan Zielen
Journal:  Clin Diagn Lab Immunol       Date:  2005-10

8.  Human immunoglobulin G (IgG) Fc receptor IIA (CD32) polymorphism and IgG2-mediated bacterial phagocytosis by neutrophils.

Authors:  L A Sanders; R G Feldman; M M Voorhorst-Ogink; M de Haas; G T Rijkers; P J Capel; B J Zegers; J G van de Winkel
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

9.  Kinetics of IgM and IgA antibody response to 23-valent pneumococcal polysaccharide vaccination in healthy subjects.

Authors:  Katharina Schütz; Richard G Hughes; Antony Parker; Isabella Quinti; Vojtech Thon; Monica Cavaliere; Martina Würfel; Wilhelm Herzog; J Engelbert Gessner; Ulrich Baumann
Journal:  J Clin Immunol       Date:  2012-09-25       Impact factor: 8.317

10.  Transplacental transmission of serotype-specific pneumococcal antibodies in a Brazilian population.

Authors:  B T Carvalho; M M Carneiro-Sampaio; D Solé; C Naspitz; L E Leiva; R U Sorensen
Journal:  Clin Diagn Lab Immunol       Date:  1999-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.